Skip to main content
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
12.89
-0.07 (-0.54%)
At close: Apr 28, 2026, 4:00 PM EDT
12.89
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:33 PM EDT

Entrada Therapeutics Revenue

In the year 2025, Entrada Therapeutics had annual revenue of $25.42M, down -87.94%. Entrada Therapeutics had revenue of $1.30M in the quarter ending December 31, 2025, a decrease of -96.53%.

Revenue (ttm)
$25.42M
Revenue Growth
-87.94%
P/S Ratio
18.25
Revenue / Employee
$167,243
Employees
152
Market Cap
464.04M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202525.42M-185.36M-87.94%
Dec 31, 2024210.78M81.77M63.38%
Dec 31, 2023129.01M--
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Valneva SE 205.07M
REGENXBIO 170.44M
Ginkgo Bioworks Holdings 170.16M
Assembly Biosciences 72.30M
XOMA Royalty 52.15M
Prelude Therapeutics 12.14M
Armata Pharmaceuticals 4.90M
Revenue Rankings

TRDA News

More News